论文部分内容阅读
心脏核磁共振成像可提供局部心肌灌注、血管再生、心肌活性以及左心室功能、左心室重塑等信息.T2-STIR压脂像可用于检测心肌梗死后水肿.由于延迟强化核磁共振成像在检测心肌微梗死和弥漫纤维化方面存在限制,作为新策略的T1均衡强化成像可用于量化存活心肌.新技术已成功用于评估心肌炎、淀粉样变、肥厚型心肌病、限制型心肌病、致心律失常右室心肌病、结节病致心力衰竭相关的弥漫心肌纤维化.未来的趋势是杂交影像的应用,如正电子发射计算机断层扫描成像/核磁共振成像,可提供更高的时间-空间分辨率.心脏核磁共振成像将会在心脏疾病的诊断中发挥重要作用.现重点综述心脏核磁共振成像在冠心病诊疗中的应用进展.“,”Magnetic resonance imaging(MRI)sequences provides complementary information on regional perfusion,angiogenesis,my-ocardial viability and left ventricular function.T2-weighted short-tau inversion recovery(T2-STIR),fat suppression have been frequently used to detect edematous area at risk of infarction.Recently,the new strategies have been developed to quantify myocardial viability using T 1-map-ping and equilibrium contrast enhanced MR techniques because existing delayed contrast enhancement MRI(DE-MRI)sequences are limited in detecting patchy microinfarction and diffuse fibrosis.These new techniques were successfully used for characterizing diffuse myocardial fi -brosis associated with myocarditis,amyloidosis,hypertrophic cardiomyopathy,congenital heart disease,restrictive cardiomyopathy,arrhythmo-genic right ventricular dysplasia and sarcoidosis heart failure.Novel trends in hybrid imaging with higher spatial-temporal resolution,such as cardiac positron emission tomography PET/MRI and cardiac MRI will be important tools for the diagnosis of cardiac diseases.This review is about the progress of application of cardiac magnetic resonance in coronary artery disease.